muscle loss on glp-1 Glucagon-like peptide-1 receptor agonists and mass effects Balancing weight and muscle loss

Clinical Update 1/04/2022 Vitamin D for Diabetic Nerve Pain

Liang X, Or B, Tsoi MF, Cheung CL, Cheung BMY

La eventual accin benfica de la liraglutida en el riesgo cardiovascular en pacientes con DM2 est siendo investigado en el estudio LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) 64

November 1, 2024: Physicians Warn People Taking Ozempic of Skeletal Muscle Mass Loss and Call for More Research Recent commentary published in JAMA warns that skeletal muscle mass (SMM) experienced while taking GLP-1 drugs may be of medical concern

Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A, et al

Most health insurance plans sort medications into three to five tiers, with higher tiers carrying higher out-of-pocket costs to the patient